The global chemical and pharmaceutical industries face increasing pressure to enhance sustainability and operational efficiency. Strict environmental regulations demand reduced solvent waste and energy consumption in purification processes. Simultaneously, the drive for higher purity in advanced materials and active pharmaceutical ingredients (APIs) necessitates breakthrough separation technologies. This patent offers a critical solution, enabling companies to meet these evolving demands, reduce their carbon footprint, and gain a competitive edge in a rapidly transforming market.
Achieves high-efficiency nano-solute separation with superior rejection rates and permeability.
Enables stable operation in organic solvent environments, expanding industrial process applications.
Establishes strong IP and market advantage through a robust patent with clarified scope, creating market entry barriers.
This is a robust patent with a clarified and strengthened scope, achieved by overcoming multiple office actions and engaging with examiners. It demonstrates clear differentiation from five prior art documents, establishing a stable right with low invalidation risk, providing a strong foundation to protect a licensee's business.
This patent primarily covers the porous hydrophobic silica membrane and its use in pervaporation for organic solvent filtration. Licensees could develop complementary IP in advanced membrane module designs, integrated process control systems, or novel applications for non-nano scale separations.
In organic solvent recovery and purification for pharmaceutical and fine chemical manufacturing, this technology could eliminate conventional distillation and multi-stage filtration, significantly reducing energy costs and processing time. For example, a company processing 100 tons of organic solvent annually could achieve a 20% reduction in processing time (saving labor and equipment operating costs) and a 5% reduction in solvent loss (saving raw material costs). This is estimated to result in over $200K/year (AI est.) in direct cost savings, based on reducing solvent recovery costs by 20% (~$35K/year (AI est.)) and solvent purchase costs by 5% (~$3.5M/year (AI est.)).
X: Filtration Precision & Separation Efficiency
Y: Organic Solvent Compatibility & Durability